Taisho Eyes First Japan Approval To Sell Lifestyle Prescription Drug OTC
This article was originally published in PharmAsia News
Executive Summary
Taisho Pharmaceutical said it plans to achieve Japan's first transfer of a drug for treating lifestyle diseases from prescription-only status to over-the-counter.